Hero Image
29 November 2021 - 30 November 2021
Second Virtual Matchmaking Event on COVID-19 Therapeutics

Welcome to

Second Virtual Matchmaking Event on COVID-19 Therapeutics

Targeted 1:1 meetings promises knowledge gain and new business contacts

The registration deadline has been extended to 23rd November 2021 (16h59 CET).

Building on the experience of the European Union (EU) Task Force for Industrial Scale-up of COVID-19 vaccines and therapeutics, the European Commission (EC) continues to facilitate cooperation between actors in the EU supply chain to ensure that available therapeutics are produced in sufficient quantity as soon as possible.

To support the industry, the Commission organises the Second Virtual Matchmaking Event on COVID-19 Therapeutics, which aims to accelerate:

  • The development of new and repurposed medicines for COVID-19 therapeutics, i.e. medicines specifically developed for an indication in treatment of COVID-19, at all stages of COVID-19 disease;
  • The development of medicines used to treat the symptoms of COVID-19;
  • The production of disposable materials (e.g. single use systems), ingredients and raw materials required for the manufacture of medicinal products; and
  • Mobilise the EU pharma manufacturing capacity for the production of medicines to treat or prevent COVID-19.

The event will take place virtually (through B2Match) on the 29th November (Monday) and 30th November  (Tuesday) 2021, in partnership with the Council of European BioRegions (CEBR) and the European Clusters Alliance (ECA). ECA and CEBR will also be our partners running the EU survey to assess EU capacities for COVID-19 therapeutics production. Logistical support is provided by GROW’s European Cluster Collaboration Platform (ECCP).

Target Group

The target group of this event is the entire EU COVID-19 therapeutics supply chain having development and/or production facilities in the EU. The event is open to EU companies and non-EU companies with research/production facilities in the European Union Member States (including companies in the portfolio of 10 most promising treatments COVID-19 Therapeutics Strategy (europa.eu), and companies in the European Economic Area. 


  • Preparatory live webinar - Wednesday, 17th November, 2021
    9h - 9:30h CET 
    ‘The EU Strategy for COVID19 therapeutics: matching capacities to increase production’. Speakers from the Task Force of Industrial Scale Up of COVID19 Vaccines and Therapeutics (DG GROW) and the Directorate General of Health and Food Safety (DG SANTE) of the European Commission. 
    Join the webinar here
  • DAY 1 - Monday, 29th November, 2021
    9:00h - 12:00h (CET) 
    - Launch of the EU matchmaking event on COVID19 Therapeutics: Experts seminar
    12:00h - 17:00h (CET) - Matchmaking meetings

  • DAY 2 - Tuesday, 30th November, 2021
    09:00 - 17:00h (CET) - 
    Matchmaking meetings

How to apply?

In order to apply to the event, European companies must comply with the requirements stated in the event's Call for Expression of Interest.


The European Commission will be glad to support and promote companies’ communication activities regarding their participation in this event, in particular any business cooperation agreements. Please tag GROW twitter account @EU_Growth or send us an email to the European Commission’s Task Force for Industrial Scale-Up of COVID19 Vaccines and therapeutics here: GROW-TFIS@ec.europa.eu